<?xml version="1.0" encoding="UTF-8"?>

<ActivityDefinition xmlns="http://hl7.org/fhir">
  <id value="TP53andDEL17pCLL"/>
  <meta>
    <profile value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/assessment-action"/>
  </meta>
  <text>
    <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ActivityDefinition TP53andDEL17pCLL</b></p><a name="TP53andDEL17pCLL"> </a><a name="hcTP53andDEL17pCLL"> </a><a name="TP53andDEL17pCLL-en-US"> </a><p><b>knowledgeCapability</b>: computable</p><p><b>knowledgeRepresentationLevel</b>: structured</p><p><b>url</b>: <a href="ActivityDefinition-TP53andDEL17pCLL.html">ActivityDefinition FISH hinsichtlich TP53 und DEL17p</a></p><p><b>version</b>: Langversion 2.01</p><p><b>name</b>: TP53andDEL17pCLL</p><p><b>title</b>: FISH hinsichtlich TP53 und DEL17p</p><p><b>status</b>: Active</p><p><b>experimental</b>: false</p><p><b>subject</b>: <span title="Codes:{http://hl7.org/fhir/fhir-types Patient}">Patient</span></p><p><b>date</b>: 2025-01-16 09:02:23+0000</p><p><b>publisher</b>: https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll</p><p><b>description</b>: </p><div><p>TP53-Deletions- und Mutationsstatus (FISH hinsichtlich del17p und TP53-Mutationsanalyse ≤ 12 Wochen vor Therapiebeginn)</p>
</div><p><b>kind</b>: ServiceRequest</p><p><b>code</b>: <span title="Codes:{http://loinc.org 103680-5}">TP53 gene full mutation analysis in Blood or Tissue by Molecular genetics method</span></p><p><b>timing</b>: Count 1  times, Once</p></div>
  </text>
  <extension url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability">
    <valueCode value="computable"/>
  </extension>
  <extension url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel">
    <valueCode value="structured"/>
  </extension>
  <url value="https://www.medizin.uni-greifswald.de/fhir/guideline/cll/ActivityDefinition/TP53andDEL17pCLL"/>
  <version value="Langversion 2.01"/>
  <name value="TP53andDEL17pCLL"/>
  <title value="FISH hinsichtlich TP53 und DEL17p"/>
  <status value="active"/>
  <experimental value="false"/>
  <subjectCodeableConcept>
    <coding>
      <system value="http://hl7.org/fhir/fhir-types"/>
      <code value="Patient"/>
    </coding>
  </subjectCodeableConcept>
  <date value="2025-01-16T09:02:23+00:00"/>
  <publisher value="https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll"/>
  <description value="TP53-Deletions- und Mutationsstatus (FISH hinsichtlich del17p und TP53-Mutationsanalyse ≤ 12 Wochen vor Therapiebeginn)"/>
  <kind value="ServiceRequest"/>
  <code>
    <coding>
      <system value="http://loinc.org"/>
      <code value="103680-5"/>
      <display value="TP53 gene full mutation analysis in Blood or Tissue by Molecular genetics method"/>
    </coding>
  </code>
  <timingTiming>
    <extension url="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/relative-time">
      <extension url="contextCode">
        <valueCodeableConcept>
          <coding>
            <system value="http://loinc.org"/>
            <code value="63936-9"/>
          </coding>
        </valueCodeableConcept>
      </extension>
      <extension url="offset">
        <valueRange>
          <low>
            <value value="-12"/>
            <system value="http://unitsofmeasure.org"/>
            <code value="wk"/>
          </low>
          <high>
            <value value="0"/>
            <system value="http://unitsofmeasure.org"/>
            <code value="wk"/>
          </high>
        </valueRange>
      </extension>
    </extension>
    <repeat>
      <count value="1"/>
    </repeat>
  </timingTiming>
</ActivityDefinition>